Qualcomm Incorporated through its wholly owned subsidiary, Qualcomm Life, Inc., today announced that the second-generation of its Capsule Vitals Plus solution has been granted 501(k) clearance from the Food & Drug Administration (FDA) and is now available for purchase. Through accurate and timely capture of medical device data and continuous monitoring of key vital signs, Capsule Vitals Plus enables integrated surveillance that moves beyond spot monitoring by capturing and analyzing data right at the bedside to support treatment decisions and care coordination.
With patient acuity levels in non-critical care on the rise and pressures to reduce length of stay, clinicians are making the transition from non-connected, episodic patient monitoring, to fully-connected integrated surveillance. This progression requires the ability to collect and analyze data, integrating clinical observations along with other contextual data types and sources to reveal patient trends directly at the bedside. The second generation Capsule Vitals Plus allows clinicians to login; associate a patient and capture their blood pressure, oxygen saturation, pulse rate and temperature; calculate an early warning score; and transmit validated data to the electronic medical record (EMR) or enterprise clinical systems directly from the patient bedside, ultimately reducing charting time from hours to minutes.
“As non-critical care environments are rapidly changing, we developed a mobile connectivity solution to increase surveillance, improve workflow and reduce patient risk,” said James Mault, MD, FACS, senior vice president and chief medical officer, Qualcomm Life, Inc. “Capsule Vitals Plus was designed by clinicians for clinicians to offer advanced usability, chartability and remote management.”
Qualcomm Incorporated (qualcomm.com) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other.
Capsule Vitals Plus is a product of Qualcomm Life, Inc.
Capsule is a trademark of Capsule Technologies SAS.
Qualcomm Contact: John Sinnott - Investor Relations
P: +1 858-658-4813 - E: ir[.]qualcomm.com.